| BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
| CCT |
|
cataract, congenital, total
|
|
|
0.588 |
0.769 |
| GCY |
|
growth control, Y chromosome influenced
|
|
|
0.631 |
0.615 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| UGT1A |
|
UDP glucuronosyltransferase family 1 member A complex locus
|
|
|
0.540 |
0.654 |
| LAP |
|
Laryngeal adductor paralysis
|
|
|
0.619 |
0.731 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| RNU1-1 |
|
RNA, U1 small nuclear 1
|
|
|
0.608 |
0.731 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| RMST |
|
rhabdomyosarcoma 2 associated transcript
|
|
|
0.769 |
0.385 |
| HOXA11-AS |
|
HOXA11 antisense RNA
|
|
|
0.610 |
0.423 |
| HCA1 |
|
Hypercalciuria, absorptive, 1
|
|
|
0.633 |
0.654 |
| H19 |
|
H19 imprinted maternally expressed transcript
|
|
|
0.494 |
0.923 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| USP17L9P |
|
ubiquitin specific peptidase 17 like family member 9, pseudogene
|
|
|
0.722 |
0.308 |
| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
| LINC01194 |
|
long intergenic non-protein coding RNA 1194
|
|
|
0.470 |
0.769 |
| MIR107 |
|
microRNA 107
|
|
|
0.543 |
0.769 |
| MIR10B |
|
microRNA 10b
|
|
|
0.509 |
0.808 |
| MIR122 |
|
microRNA 122
|
|
|
0.468 |
0.808 |
| MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |
| MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
| MIR130A |
|
microRNA 130a
|
|
|
0.522 |
0.808 |